Vertex Pharmaceuticals Incorporated has a market cap of $12.82 billion; its shares were traded at around $58.48 with a P/E ratio of 28.8 and P/S ratio of 9.1.
This is the insider trade history vs. stock price of VRTX. For the complete insider trading history of VRTX, click here.
Directors and Officers Recent Trades:
- Director Joshua S Boger sold 4,000 shares of VRTX stock on 10/03/2012 at the average price of 57.74. Joshua S Boger owns at least 946,181 shares after this. The price of the stock has increased by 1.28% since.
- Director Joshua S Boger sold 4,000 shares of VRTX stock on 09/26/2012 at the average price of 55.07. Joshua S Boger owns at least 946,181 shares after this. The price of the stock has increased by 6.19% since.
- SVP, Corp Affairs & Pub Policy Amit Sachdev sold 9,531 shares of VRTX stock on 09/21/2012 at the average price of 59. Amit Sachdev owns at least 21,770 shares after this. The price of the stock has decreased by 0.88% since.
- SVP, Human Resources Lisa Kelly sold 4,047 shares of VRTX stock on 09/19/2012 at the average price of 57.61. Lisa Kelly owns at least 19,206 shares after this. The price of the stock has increased by 1.51% since.
- Director Joshua S Boger sold 4,000 shares of VRTX stock on 09/19/2012 at the average price of 57.66. Joshua S Boger owns at least 946,181 shares after this. The price of the stock has increased by 1.42% since.
For the complete insider trading history of VRTX, click here.







RSS